C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Patents for C07C 323 - Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups (27,160)
11/2004
11/23/2004	US6821960 Glucagon antagonists/inverse agonists
11/23/2004	CA2310745C Oxygen scavenging hydrotalcite and compositions containing same
11/18/2004	WO2004099171A2 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	WO2004099150A2 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/18/2004	WO2004099129A2 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
11/18/2004	WO2004098516A2 Cyclic derivatives as modulators of chemokine receptor activity
11/18/2004	US20040230079 alkoxide and hydroxide induced nucleophilic trifluoromethylation of carbonyl compounds, disulfides and other electrophiles, using phenyl trifluoromethyl sulfone PhSO2CF3 (or sulfoxide PhSOCF3); high diastereoselectivity; preparing 2,2-difluoropropan-diols directly from carbonyl compounds
11/18/2004	US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229949 New 3-aryl propionic acid derivatives and analogs
11/18/2004	US20040229946 Antidiabetic agents
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229869 For prophylaxis and therapy of medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma
11/18/2004	CA2524927A1 Intermediates useful in the synthesis of hiv-protease inhibitors and methods for preparing the same
11/18/2004	CA2523718A1 Substituted amino carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/18/2004	CA2523235A1 3-(1-naphthyl)-2-cyanopropanoic acid derivatives as estrogen receptor ligands
11/17/2004	EP1476753A2 Functionalized compositions for improved immobilization
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	EP1210333B1 p-Tolyl-heterocycles as herbicides
11/17/2004	EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004	CN1546462A Insecticidal antibacterial sulphur , oxygen and oxime-containing ether compounds
11/17/2004	CN1176071C Process for preparation of 2-alkylthio benzoic acid derivatives
11/17/2004	CN1176066C 1,1-and 1,2-disubsitituted cyclopropane compounds, preparation method thereof and drug compositions containing the same
11/17/2004	CN1175807C Disulfide derivatives useful for treating allergic diseases
11/16/2004	US6818775 Treatment of skin-related diseases or prevention of certain undesired side effects of administered retinoids
11/16/2004	US6818666 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
11/16/2004	US6818660 Calcilytic compounds
11/16/2004	US6818423 Process for the preparation of chiral α-hydroxycarboxylic acids
11/16/2004	CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004	WO2004096761A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
11/11/2004	WO2004081073A3 Methods for selectively removing counterions from compounds and compounds derived from such methods
11/11/2004	US20040225160 Process for functionalizing a double bond
11/11/2004	US20040225150 Methods for selectively removing counterions from compounds and compounds derived from such methods
11/11/2004	US20040225021 Polyamine compounds and compositions for use in conjunction with cancer therapy
11/11/2004	US20040224941 Carboxylic acid derivatives and drugs containing the same as the active ingredient
11/11/2004	US20040224366 Valency platform molecules comprising aminooxy groups
11/11/2004	DE10317878A1 Verfahren zur Herstellung von alpha-methylierten Cystein und Serin-Derivaten A process for preparing alpha-methylated cysteine and serine derivatives
11/11/2004	CA2523585A1 Aromatic oxyphenyl and aromatic sulfanylphenyl derivatives
11/10/2004	EP1474387A2 Derivatives of alpha-phenylthiocarboxylic and alpha-phenyloxy-carboxylic acids useful for the treatment of diseases responding to ppar alpha activation
11/10/2004	EP1474386A1 Process for the preparation of 1-(mercaptomethyl)-cyclopropaneacetic acid
11/10/2004	EP1474374A1 Method for the purification of acrolein
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1174955C 3-amino-2-benzyl-1-phenyl-propane derivs.
11/09/2004	US6815567 Manufacturing of molecular electronic device, nitration, esterification, hydrolysis, sulfiding
11/09/2004	US6815560 Process for the preparation of hydroxymethylbutyric acid
11/09/2004	CA2126195C Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
11/04/2004	WO2004094650A2 Synthesis of labeled metabolites
11/04/2004	WO2004094362A1 CaSR ANTAGONIST
11/04/2004	WO2004093800A2 Thyronamine derivatives and analogs and methods of use thereof
11/04/2004	WO2004078765A3 Catalysts for the polymerization of styrene
11/04/2004	WO2003077847A3 Substituted amides
11/04/2004	US20040220310 Organic thiol metal-free stabilizers and plasticizers for halogen-containing polymers
11/04/2004	US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004	US20040220074 Compounds for a controlled release of active molecules
11/04/2004	US20040220055 Benzamidoacetonitriles and their use as antiparastics
11/04/2004	CA2517560A1 Thyronamine derivatives and analogs and methods of use thereof
11/03/2004	EP1472576A2 Sulfonate derivatives and the use therof as latent acids
11/03/2004	EP1472541A1 Imaging agents and methods of imaging naaladase of psma
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1445251A9 Aminoacetonitrile derivative, agricultural and horticultural insecticide containing the same, and use thereof
11/03/2004	EP1290001B1 Process for the selective deprotonation and functionalization of 3-substituted benzotrifluorides
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004	CN1173943C Process for preparing 2-hydroxy-4-methylthiobutanoic acid
11/03/2004	CN1173697C Aniline disulfide derivatives for treating allergic diseases
11/02/2004	US6812364 Central nervous system disorders; psychological disorders; anticancer agents
11/02/2004	US6812250 Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
11/02/2004	US6812229 Carbamate derivative and agricultural/horticultural fungicide
11/02/2004	US6811833 Birefringement film
11/02/2004	CA2153903C Process for the preparation of 10-desacetoxybaccatin iii
10/2004
10/28/2004	WO2004092184A1 Technetium-labelled fatty acids and their use in myocardial diagnostics, in addition to a method for producing said technetium-labelled fatty acids
10/28/2004	WO2004092119A2 Method for producing alpha-methylated cysteine and serine derivatives
10/28/2004	WO2004091724A1 Anthranilic acid derivatives useful in treating infection with hepatitis c virus
10/28/2004	WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004	WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004	US20040214930 Compounds such as S-substituted 4(3-mercapto/sulfinyl-2-hydroxypropylamino)diphenylamine as as stabilizers for elastomers
10/28/2004	US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214874 Inhibition of protein-tyrosine kinase cmet to block cancer cell proliferation, oral bioavailibility; 2-(2,6-dichlorophenyl)-4-phenyl-5-(pyrimidin-4yl)-1H-imidazoles
10/28/2004	US20040213442 Novel fatty acids analogous
10/28/2004	DE10316110A1 Verfahren zur Herstellung von 2-Hydroxy-4-methylthio-buttersäure Ammoniumsalz A process for the preparation of 2-hydroxy-4-methylthiobutyric acid ammonium salt
10/28/2004	CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/27/2004	EP1471052A1 Geranyl compounds
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1470752A1 Insecticides containing hydrazone derivatives as the active ingredient and novel hydrazone derivatives
10/27/2004	EP1272456B1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/27/2004	EP1265940B1 Aromatic amine curatives and their use
10/27/2004	CN1540764A Organophotoreceptor with charge transport material having two hydrazone groups
10/27/2004	CN1539819A Method for preparing zinc trace element in additive of hydroxy methinine
10/27/2004	CN1539816A IL-8 receptor antagonist
10/27/2004	CN1172980C Stabilizers and antiozonants for elastomers
10/27/2004	CN1172918C Isothizole derivatives useful anticancer agents
10/26/2004	US6809091 Substances capable of inducing apoptosis
10/26/2004	CA2301818C Bifunctional compounds useful in catalyst reporter deposition
10/26/2004	CA2120812C Improved process for manufacturing l-(-)-carnitine from a waste product having opposite configuration
10/21/2004	WO2004090152A1 2-alkylcysteinamide or salt thereof, process for producing these, and use of these
10/21/2004	WO2004089886A1 Pleuromutilin derivatives, process for their preparation and uses thereof
10/21/2004	WO2004089885A1 Novel compounds
10/21/2004	WO2004089876A1 Biphenylcarboxylic amide derivatives as p38 kinease inhibitors

1 ... 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 ... 272